Psychopharmacological Strategies Employing Guanfacine in an Adolescent Girl with Postural Orthostatic Tachycardia Syndrome and Severe Posttraumatic Stress Disorder
- PMID: 35587210
- PMCID: PMC9545804
- DOI: 10.1089/cap.2022.29221.bjc
Psychopharmacological Strategies Employing Guanfacine in an Adolescent Girl with Postural Orthostatic Tachycardia Syndrome and Severe Posttraumatic Stress Disorder
Similar articles
-
Guanfacine as a Treatment for Posttraumatic Stress Disorder in an Adolescent Female.J Child Adolesc Psychopharmacol. 2020 Jul;30(6):398-401. doi: 10.1089/cap.2020.29186.bjc. Epub 2020 Jun 17. J Child Adolesc Psychopharmacol. 2020. PMID: 32551846 No abstract available.
-
No improvement of posttraumatic stress disorder symptoms with guanfacine treatment.Am J Psychiatry. 2006 Dec;163(12):2186-8. doi: 10.1176/appi.ajp.163.12.2186. Am J Psychiatry. 2006. PMID: 17151174 Clinical Trial.
-
Postural changes in optic nerve and optic nerve sheath diameters in postural orthostatic tachycardia syndrome and spontaneous intracranial hypotension: A cohort study.PLoS One. 2019 Oct 9;14(10):e0223484. doi: 10.1371/journal.pone.0223484. eCollection 2019. PLoS One. 2019. PMID: 31596889 Free PMC article.
-
Treatment of Postural Orthostatic Tachycardia Syndrome With Medication: A Systematic Review.J Child Neurol. 2020 Dec;35(14):1004-1016. doi: 10.1177/0883073820948679. Epub 2020 Aug 24. J Child Neurol. 2020. PMID: 32838632
-
Postural orthostatic tachycardia syndrome for the otolaryngologist.Laryngoscope. 2017 May;127(5):1195-1198. doi: 10.1002/lary.26269. Epub 2016 Aug 31. Laryngoscope. 2017. PMID: 27578452 Review.
Cited by
-
Guanfacine as an Adjunct Treatment for Complex Post-Traumatic Stress Disorder: A Case Report.J Korean Acad Child Adolesc Psychiatry. 2025 Apr 1;36(2):78-82. doi: 10.5765/jkacap.240037. J Korean Acad Child Adolesc Psychiatry. 2025. PMID: 40203142 Free PMC article.
-
Efficacy of Guanfacine for Self-injurious and Aggressive Behaviors through the Reduction of Impulsivity in Borderline Personality Disorder: Two Case Reports and a Literature Review.Clin Psychopharmacol Neurosci. 2025 Aug 31;23(3):520-525. doi: 10.9758/cpn.24.1263. Epub 2025 Mar 17. Clin Psychopharmacol Neurosci. 2025. PMID: 40660699 Free PMC article.
-
Alpha-2 Agonists in Children and Adolescents With Post-traumatic Stress Disorder: A Systematic Review.Cureus. 2024 Jan 26;16(1):e53009. doi: 10.7759/cureus.53009. eCollection 2024 Jan. Cureus. 2024. PMID: 38410304 Free PMC article. Review.
-
Anxiety and dysautonomia symptoms in patients with a NaV1.7 mutation and the potential benefits of low-dose short-acting guanfacine.Clin Auton Res. 2024 Feb;34(1):191-201. doi: 10.1007/s10286-023-01004-1. Epub 2023 Dec 8. Clin Auton Res. 2024. PMID: 38064009 Free PMC article.
References
-
- Akinsanya A, Marwaha R, Tampi RR: Prazosin in children and adolescents with posttraumatic stress disorder who have nightmares: A systematic review. J Clin Psychopharmacol 37:84–88, 2017. - PubMed
-
- Anderson J, Wang C, Zaidi A, Rice T, Coffey BJ: Guanfacine as a treatment for posttraumatic stress disorder in an adolescent female. J Child Adolesc Psychopharmacol 30:398–401, 2020. - PubMed
-
- Auxéméry Y: [Posttraumatic stress disorder (PTSD) as a consequence of the interaction between an individual genetic susceptibility, a traumatogenic event and a social context]. Encephale 38:373–380, 2012. - PubMed
-
- Biederman J, Melmed RD, Patel A, McBurnett K, Donahue J, Lyne A: Long-term, open-label extension study of guanfacine extended release in children and adolescents with ADHD. CNS Spectr 13:1047–1055, 2008. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical